Fibrx Therapeutics Inc FBRX
News
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Shares Outstanding
- —
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Fibrx Therapeutics Inc is a clinical-stage biotechnology company focused on the development of novel, small molecule, targeted medicines for fibrotic disease. The company's flagship program is RXC008, a GI-restricted pan-ROCK inhibitor for the treatment of fibrostenotic Crohn's disease. Its pipeline also includes zelasudil (RXC007), a next-generation selective ROCK2 inhibitor, and a pre-clinical Discoidin Domain Receptor (DDR) inhibitor program.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- —
- Total Number of Employees
- —
- Website
- —
Valuation
Metric | FBRX |
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
Metric | FBRX |
|---|---|
Quick Ratio | 0.35 |
Current Ratio | 0.42 |
Interest Coverage | — |
Quick Ratio
FBRX
Profitability
Metric | FBRX |
|---|---|
Return on Assets (Normalized) | −94.77% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −111.75% |
Return on Assets
FBRX
Biotechnology Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc VRTX | LOCK|%HvM@C& | LOCK|$l@& | $137B | |||
| Regeneron Pharmaceuticals Inc REGN | LOCK|MHR$#zP | LOCK|Px$% | $99B | |||
| Moderna Inc MRNA | LOCK|l#nLQT | LOCK|SK | $90B | |||
| argenx SE ADR ARGX | LOCK|&G^$KXC | LOCK|Gh | $61B | |||
| BeOne Medicines Ltd ADR ONC | LOCK|%yp<&Z | LOCK|PJ | $48B | |||
| Royalty Pharma PLC Class A RPRX | LOCK|^zPfnhd! | LOCK|@rR$ | $31B | |||
| Incyte Corp INCY | LOCK|ZPpjQl@ | LOCK|!T | $25B | |||
| Alnylam Pharmaceuticals Inc ALNY | LOCK|H@$>$h | LOCK|L@sS | $22B | |||
| BioNTech SE ADR BNTX | LOCK|b&?SJxR | LOCK|>Z | $21B | |||
| Jazz Pharmaceuticals PLC JAZZ | LOCK|#>!c?qr | LOCK|#? | $16B |